A detailed history of Cooper Financial Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cooper Financial Group holds 13,873 shares of BMY stock, worth $822,252. This represents 0.1% of its overall portfolio holdings.

Number of Shares
13,873
Previous 18,768 26.08%
Holding current value
$822,252
Previous $779,000 7.96%
% of portfolio
0.1%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $194,135 - $253,316
-4,895 Reduced 26.08%
13,873 $717,000
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $129,927 - $171,051
-3,228 Reduced 14.68%
18,768 $779,000
Q1 2024

Apr 11, 2024

BUY
$47.98 - $54.4 $121,821 - $138,121
2,539 Added 13.05%
21,996 $1.19 Million
Q4 2023

Jan 16, 2024

BUY
$48.48 - $57.85 $23,706 - $28,288
489 Added 2.58%
19,457 $998,000
Q3 2023

Oct 13, 2023

BUY
$57.89 - $64.73 $23,561 - $26,345
407 Added 2.19%
18,968 $1.1 Million
Q2 2023

Jul 07, 2023

BUY
$63.71 - $70.74 $184,313 - $204,650
2,893 Added 18.46%
18,561 $1.19 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $69,718 - $79,076
1,061 Added 7.26%
15,668 $1.09 Million
Q4 2022

Jan 13, 2023

BUY
$68.48 - $81.09 $97,447 - $115,391
1,423 Added 10.79%
14,607 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $268 - $158,981
2,069 Added 18.61%
13,184 $937,000
Q2 2022

Jul 11, 2022

BUY
$72.62 - $79.98 $121,202 - $133,486
1,669 Added 17.67%
11,115 $856,000
Q1 2022

Apr 12, 2022

BUY
$61.48 - $73.72 $20,411 - $24,475
332 Added 3.64%
9,446 $690,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $64,195 - $74,836
-1,197 Reduced 11.61%
9,114 $568,000
Q3 2021

Oct 06, 2021

BUY
$59.17 - $69.31 $25,975 - $30,427
439 Added 4.45%
10,311 $610,000
Q2 2021

Jul 12, 2021

BUY
$61.91 - $67.42 $4,828 - $5,258
78 Added 0.8%
9,872 $660,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $213,920 - $240,597
-3,605 Reduced 26.9%
9,794 $618,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $197,528 - $223,836
3,421 Added 34.29%
13,399 $831,000
Q3 2020

Oct 09, 2020

BUY
$57.43 - $63.64 $7,121 - $7,891
124 Added 1.26%
9,978 $602,000
Q2 2020

Jul 15, 2020

BUY
$54.82 - $64.09 $230,518 - $269,498
4,205 Added 74.44%
9,854 $579,000
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $48,720 - $70,801
1,050 Added 22.83%
5,649 $315,000
Q4 2019

Jan 07, 2020

BUY
$49.21 - $64.19 $226,316 - $295,209
4,599 New
4,599 $295,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.